Shuya Yang

5PUBLICATIONS
1CO-AUTHORS
Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 13, 2025
Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm.

Yuanli He, Chenchen Hu, Feiming Hu

|Aug 13, 2025
IGF2BP3 as a Novel Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma.

Feiming Hu, Chenchen Hu, Yuanli He

|Jan 25, 2025
TLR7: A Key Prognostic Biomarker and Immunotherapeutic Target in Lung Adenocarcinoma.

Feiming Hu, Chenchen Hu, Yuanli He

|Nov 27, 2024
Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment.

Jing Wang, Yuanli He, Feiming Hu

|Feb 14, 2024
IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD.

Chenying Han, Chenchen Hu, Tianyue Liu

Pageof 1

Frequent Collaborators

3 joint publications

Dongbo Jiang